Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Heart failure

Early follow-up after hospitalization for heart failure

Nature Reviews Cardiology volume 7, pages 422–424 (2010)Cite this article

Subjects

Admissions for heart failure are associated with an unacceptably high rate of early readmission and mortality. An early postdischarge visit with targeted interventions in high-risk patients may decrease this high event rate. Determining who should be seen early postdischarge and what should be done during the visit remains to be established.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Adjusted risk of cardiovascular rehospitalization or death in patients with heart failure enrolled in the EVEREST trial.

References

  1. Gheorghiade, M. et al. for the OPTIMIZE-HF Investigators and Coordinators. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA 296, 2217–2226 (2006).

    Article  CAS  Google Scholar 

  2. Hernandez, A. F. et al. Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA 303, 1716–1722 (2010).

    Article  CAS  Google Scholar 

  3. Gheorghiade, M. & Pang, P. S. Acute heart failure syndromes. J. Am. Coll. Cardiol. 53, 557–573 (2009).

    Article  Google Scholar 

  4. Gheorghiade, M. et al. for the EVEREST Investigators. Changes in clinical, neurohormonal, electrolyte, renal, and hepatic profiles during and after hospitalization for acute decompensated heart failure: analysis from the EVEREST trial (late breaking clinical trial). Presented at the European Society of Cardiology Congress 2008 [online], (2008).

  5. O'Connor, C. M. et al. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am. Heart J. 156, 662–673 (2008).

    Article  Google Scholar 

  6. O'Connor, C. M. et al. for the EVEREST Investigators. Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program. Am. Heart J. 159, 841e1–849e1 (2010).

    Article  Google Scholar 

  7. Dunlay, S. M. et al. Critical elements of clinical follow-up after hospital discharge for heart failure: insights from the EVEREST trial. Eur. J. Heart Fail. 12, 367–374 (2010).

    Article  Google Scholar 

  8. Gheorghiade, M. & Braunwald, E. Reconsidering the role for digoxin in the management of acute heart failure syndromes. JAMA 302, 2146–2147 (2009).

    Article  Google Scholar 

  9. Wang, N. C. et al. for the EVEREST Investigators. Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction. JAMA 299, 2656–2666 (2008).

    Article  CAS  Google Scholar 

  10. Soukoulis, V. et al. Micronutrient deficiencies an unmet need in heart failure. J. Am. Coll. Cardiol. 54, 1660–1673 (2009).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Center for Cardiovascular Quality and Outcomes, Northwestern University Feinberg School of Medicine, 645 N Michigan Avenue, Suite 1006, Chicago, 60611, IL, USA

    Mihai Gheorghiade & Robert O. Bonow

Authors
  1. Mihai Gheorghiade
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert O. Bonow
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mihai Gheorghiade.

Ethics declarations

Competing interests

M. Gheorghiade is a consultant for and received grants from BayerScheringPharma, DebioPharm, Medtronic, Novartis Pharma, Otsuka Pharmaceuticals, PeriCor Therapeutics, Sigma Tau, and Solvay Pharmaceuticals, and is a consultant for Abbott Labs, Astellas Pharma, AstraZeneca, Corthera, Cytokinetics, ErreKappa Terapeutici, GlaxoSmithKline, Johnson & Johnson, Merck, Protein Design Laboratories, and Sanofi-Aventis. R. O. Bonow declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gheorghiade, M., Bonow, R. Early follow-up after hospitalization for heart failure. Nat Rev Cardiol 7, 422–424 (2010). https://doi.org/10.1038/nrcardio.2010.102

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrcardio.2010.102

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing